Shaoqiang Li

7PUBLICATIONS
40CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 25, 2026
Deubiquitinase USP32 stabilizes DDX17 to promote tumor progression and lenvatinib resistance in hepatocellular carcinoma via the miR-3163/MAPK pathway.

|Apr 02, 2025
Syntaxin-6 mediated autophagy confers lenvatinib resistance in hepatocellular carcinoma.

Guo-Pei Zhang, Ze-Bing Song, De-Hua Chen

|May 14, 2023
The influence of the extent of lymph node metastasis on the prognosis for patients with intrahepatic cholangiocarcinoma.

Jianping Wang, Man Shu, Hong Peng

|Nov 17, 2022
Adjuvant transarterial chemoembolization for intermediate-stage hepatocellular carcinoma with microvascular invasion.

Xiao-Hui Wang, Qun-Fang Zhou, Chen-Meng Wang

|May 23, 2022
Emerging Roles of the Copper-CTR1 Axis in Tumorigenesis.

Yaqing Su, Xiaomei Zhang, Shaoqiang Li

|Apr 27, 2022
Combination Neoantigen-Based Dendritic Cell Vaccination and Adoptive T-Cell Transfer Induces Antitumor Responses Against Recurrence of Hepatocellular Carcinoma.

Sui Peng, Shuling Chen, Wei Hu

Pageof 2

Frequent Collaborators

3 joint publications

Ming Kuang

2 joint publications

Dongming Li

2 joint publications

Zebin Chen

1 joint publications

Xiao-Hui Wang